STRONG REBOUND EXPECTED!!! GOOD SHORT-TERM BUY OPPORTUNITY

A phase two study is expected “in the next couple of months,”

Source: cnbc.com/2021/02/03/covid-vaccine-vaxart-says-its-oral-vaccine-got-promising-results.html